ESC Professional Premium Access

Genes and cardiomyopathies

Event: ESC Congress 2022
Topic: Clinical
Session type: Moderated ePosters
Date: 28 August 2022
Time: 13:15 - 14:00

Congress Session

7 presentations in this session

Family screening in dilated cardiomyopathy- qualifying screening and need for follow-up

Speaker: Doctor C. Vissing (Copenhagen, DK)

Prognostic prediction of genotype versus phenotype in genetic cardiomyopathies

Speaker: Doctor A. Paldino (Trieste, IT)

Mechano-energetic efficiency in patients with hypertrophic cardiomyopathy with and without sarcomeric mutations.

Speaker: Doctor F. Borrelli (Naples, IT)

Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy

Speaker: Doctor C. Lee (New York, US)

A multi-modality, multi-parametric phenotyping study of transthyretin amyloid cardiomyopathy associated with the p.V142I TTR variant.

Speaker: Doctor Y. Razvi (London, GB)

Different prognosis of ARVC patients between DSG2 and PKP2 variant carriers

Speaker: Doctor K. Sonoda (Osaka, JP)

ACE values in the diagnosis of sarcoidosis

Speaker: Doctor H. Kawai (Toyoake, JP)

7 speakers from this session

Doctor Christoffer Rasmus Vissing

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Doctor Alessia Paldino

United Hospitals of Trieste University Hospital, Trieste (Italy)
0 follower

Doctor Felice Borrelli

Federico II University Hospital, Naples (Italy)
0 follower

Doctor Charlotte Lee

Columbia University Medical Center, New York (United States of America)
0 follower

Doctor Yousuf Razvi

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Keiko Sonoda

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)
0 follower

Doctor Hideki Kawai

Fujita Health University, Toyoake (Japan)
0 follower

This platform is supported by

logo Novo Nordisk